The Traceability Gap: Managing Risk Across Suppliers Beyond Tier 1
click here to discover importer exporter profiles & logistic partners
Shipments
Trading Partners
Markets
Products/HS Code
Exports Data of
m/s harbin pharmaceutical group bioengineering
co. ltd no. 99 zhuhai road limindevelopment zone, hulan dsitrictharbin china 150025sdnf, china
m/s harbin pharmaceutical group bioengineering is based out of china with 9 export shipments recorded in global import export data.
Trade Trends of m/s harbin pharmaceutical group bioengineering
from Jan 2022 to Sept 2025Shipments Imported: 0
As Buyer Trade Value (USD): $0
Shipments Exported: 9
As Supplier Trade Value (USD): $437.43 K
Import and Export shipments of "m/s harbin pharmaceutical group bioengineering"
As Supplier
| Consignee Name | Shipper Name | HS Code | Port of Unlading | Product Keywords | Shipment Date |
|---|---|---|---|---|---|
| 300490 | karachi, sindh, pakistan | MEDICIN FOR KIDNEY) RECOMBINANT HUMAN ERYTHROPOIETIN FOR INJECTION (INJECTION TROPIN) 4000IU/PFS. BATCH NO: 20250701 REG NO. 084834 M. 01-07.2025 E. 30.06.2027. (25000 PFS @ US$. 1.50 PER PFS)(PREVIOUS EVIDENCE VIDE GD NO: KPAF-HC-70243-23-05-2025) | Aug 22, 2025 | ||
avior pharmaceuticals pvt ltd | m/s harbin pharmaceutical group bioengineering | 300490 | karachi, sindh, pakistan | MEDICIN FOR KIDNEY) RECOMBINANT HUMAN ERYTHROPOIETIN FOR INJECTION (INJECTION TROPIN) 4000IU/PFS. BATCH NO: 20250701 REG NO. 084834 M. 01-07.2025 E. 30.06.2027. (25000 PFS @ US$. 1.50 PER PFS)(PREVIOUS EVIDENCE VIDE GD NO: KPAF-HC-70243-23-05-2025) | Aug 22, 2025 |
avior pharmaceuticals pvt ltd | m/s harbin pharmaceutical group bioengineering | 300490 | karachi, sindh, pakistan | MEDICIN FOR KIDNEY) RECOMBINANT HUMAN ERYTHROPOIETIN FOR INJECTION (INJECTION TROPIN) 4000IU/PFS. BATCH NO: 20250701 REG NO. 084834 M. 01-07.2025 E. 30.06.2027. (25000 PFS @ US$. 1.50 PER PFS)(PREVIOUS EVIDENCE VIDE GD NO: KPAF-HC-70243-23-05-2025) | Aug 22, 2025 |
avior pharmaceuticals pvt ltd | m/s harbin pharmaceutical group bioengineering | 300490 | karachi, sindh, pakistan | MEDICIN FOR KIDNEY) RECOMBINANT HUMAN ERYTHROPOIETIN FOR INJECTION (INJECTION TROPIN) 4000IU/PFS. BATCH NO: 20250701 REG NO. 084834 M. 01-07.2025 E. 30.06.2027. (25000 PFS @ US$. 1.50 PER PFS)(PREVIOUS EVIDENCE VIDE GD NO: KPAF-HC-70243-23-05-2025) | Aug 22, 2025 |
avior pharmaceuticals pvt ltd | m/s harbin pharmaceutical group bioengineering | 300490 | karachi, sindh, pakistan | MEDICIN FOR KIDNEY) RECOMBINANT HUMAN ERYTHROPOIETIN FOR INJECTION (INJECTION TROPIN) 4000IU/PFS. BATCH NO: 20250701 REG NO. 084834 M. 01-07.2025 E. 30.06.2027. (25000 PFS @ US$. 1.50 PER PFS)(PREVIOUS EVIDENCE VIDE GD NO: KPAF-HC-70243-23-05-2025) | Aug 22, 2025 |
Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.
Solutions Built for Every Stage of Global Trade
Global Trade Management
Discover end-to-end compliance automation across classification, screening, and duties.
Know more
Intel
Discover high-potential prospects, qualify opportunities, and grow your pipeline.
Know more
SourceAtlas
Discover suppliers, compare sourcing markets, and make smarter sourcing decisions.
Know more
Trading Partners of m/s harbin pharmaceutical group bioengineering
Top Companies "m/s harbin pharmaceutical group bioengineering" is exporting to (by Value USD)
| Buyer | 2025 | 2024 |
|---|---|---|
drug international ltd | 76.08 K | 266.01 K |
avior pharmaceuticals pvt ltd | 95.35 K | - |
Markets in which m/s harbin pharmaceutical group bioengineering trades
Top Countries "m/s harbin pharmaceutical group bioengineering" is exporting to (by Value USD)
| Importing Country | 2025 | 2024 |
|---|---|---|
 bangladesh | 76.08 K | 266.01 K |
 pakistan | 95.35 K | - |
Products/HS Codes traded by m/s harbin pharmaceutical group bioengineering
Top HS Codes Exported by "m/s harbin pharmaceutical group bioengineering"
USD 164.68 K | 33.33%
Organic chemicals Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. - Other
Organic chemicals Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. - Other
USD 95.35 K | 33.33%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
USD 101.32 K | 22.22%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Other
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Other
USD 76.08 K | 11.11%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Other
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Other
Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Similar Companies to m/s harbin pharmaceutical group bioengineering
Companies exporting similar HS Codes as of "m/s harbin pharmaceutical group bioengineering" in china
Other Buyers and Suppliers in china who deal in similar products like m/s harbin pharmaceutical group bioengineering
Explore Transformation Stories
How a US Freight Forwarder Generated
4x More Leads at $1 Cost Per Lead
Trademo’s global trade intelligence platform has allowed us to find leads easily, boosting the team’s productivity and making the process simpler.
Iliana Rodriguez
Operations Team Leader
Frequently Asked Questions
Who are the top buyers purchasing from M/s Harbin Pharmaceutical Group Bioengineering?
According to trade records, some of the top buyers of M/s Harbin Pharmaceutical Group Bioengineering include Drug International Ltd And Avior Pharmaceuticals Pvt Ltd.
Which countries does M/s Harbin Pharmaceutical Group Bioengineering trade with?
Customs data shows that M/s Harbin Pharmaceutical Group Bioengineering is most active in trade with countries such as Bangladesh And Pakistan.
How many shipments has M/s Harbin Pharmaceutical Group Bioengineering in last 12 months?
In last 12 months, M/s Harbin Pharmaceutical Group Bioengineering has been linked to 9 verified shipments tracked through international trade data.
What is the total export value of M/s Harbin Pharmaceutical Group Bioengineering in last 12 months?
The total recorded export value of M/s Harbin Pharmaceutical Group Bioengineering is estimated at $437.43 K till date, based on aggregated global shipment sources.
How can I analyze M/s Harbin Pharmaceutical Group Bioengineering global trade network?
With Trademo, you can explore M/s Harbin Pharmaceutical Group Bioengineering complete trade ecosystem including buyers, manufacturers, shipment volumes, and trade routes, helping you identify opportunities and risks.
APIs
Data License
Plans
Directories
Company
Location
United States
3000 El Camino Real, Building 4, Suite 200, Palo Alto, California 94306
India
2nd Floor, Plot No. 136, Sector 44, Gurugram, Haryana 122003
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.